Back to Search
ROBERT O'DONNELL, D.O.
D.O.
Obstetrics & Gynecology Physician
NPI: 1801836895IndividualAccepts Medicare
Specialties, Licenses & Credentials
Obstetrics & Gynecology PhysicianPrimary
Obstetrics & Gynecology
Code: 207V00000X
MB58041(NJ)
CMS Specialties
PrimaryOBSTETRICS/GYNECOLOGY
Education
AT STILL UNIVERSITY OF HEALTH SCIENCES, COLLEGE OF OSTEO MED, KIRKSVILLE
Class of 1990
Research & Publications (20)
Development and characterization of CD22-targeted pegylated-liposomal doxorubicin (IL-PLD).
PMID 19306119·Invest New Drugs·2010
8-other
Compress periprosthetic fractures: interface stability and ease of revision.
PMID 19565305·Clin Orthop Relat Res·2009
8-other
Detection of cocaine and its metabolites in urine using solid phase extraction-ion mobility spectrometry with alternating least squares.
PMID 19457629·Forensic Sci Int·2009
8-other
Utility of immunohistochemistry for endothelial markers in distinguishing epithelioid hemangioendothelioma from carcinoma metastatic to bone.
PMID 19492891·Arch Pathol Lab Med·2009
8-other
Successful treatment of high risk and recurrent pediatric desmoids using radiation as a component of multimodality therapy.
PMID 19410386·Int J Radiat Oncol Biol Phys·2009
8-other
A novel family of Apicomplexan glideosome-associated proteins with an inner membrane-anchoring role.
PMID 19561073·J Biol Chem·2009
7-preclinical
Influence of symptomatic status on the prevalence of obstructive coronary artery disease in patients with zero calcium score.
PMID 18774135·Atherosclerosis·2009
8-other
Treatment of non-Hodgkin's lymphoma xenografts with the HB22.7 anti-CD22 monoclonal antibody and phosphatase inhibitors improves efficacy.
PMID 19294384·Cancer Immunol Immunother·2009
7-preclinical
Dose, timing, schedule, and the choice of targeted epitope alter the efficacy of anti-CD22 immunotherapy in mice bearing human lymphoma xenografts.
PMID 19437017·Cancer Immunol Immunother·2009
7-preclinical
Phosphatase inhibition augments anti-CD22-mediated signaling and cytotoxicity in non-hodgkin's lymphoma cells.
PMID 19237192·Leuk Res·2009
8-other
Radionuclide impurities in proton-irradiated [18O]H2O for the production of 18F-: activities and distribution in the [18F]FDG synthesis process.
PMID 19111472·Appl Radiat Isot·2009
8-other
Early discharge care with ongoing follow-up support may reduce hospital readmissions in COPD.
PMID 19436695·Int J Chron Obstruct Pulmon Dis·2009
8-other
Compressive osseointegration of tibial implants in primary cancer reconstruction.
PMID 19653050·Clin Orthop Relat Res·2009
8-other
Immunostaining for peroxisome proliferator gamma distinguishes dedifferentiated liposarcoma from other retroperitoneal sarcomas.
PMID 18204431·Mod Pathol·2008
8-other
Flying the murky skies. The roles nurses can play in solving 'never events'.
PMID 18777686·Mod Healthc·2008
8-other
Immunohistochemical method identifies lymphovascular invasion in a majority of oral squamous cell carcinomas and discriminates between blood and lymphatic vessel invasion.
PMID 18505934·J Histochem Cytochem·2008
8-other
MSP1(19) miniproteins can serve as targets for invasion inhibitory antibodies in Plasmodium falciparum provided they contain the correct domains for cell surface trafficking.
PMID 18333885·Mol Microbiol·2008
7-preclinical
Distribution and prognostic significance of human telomerase reverse transcriptase (hTERT) expression in giant-cell tumor of bone.
PMID 18204433·Mod Pathol·2008
8-other
Deletion of the Plasmodium falciparum merozoite surface protein 7 gene impairs parasite invasion of erythrocytes.
PMID 18820076·Eukaryot Cell·2008
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 1 BAY AVE
MONTCLAIR, NJ 07042 - Phone
- (973) 429-6930
Quick Facts
- NPI
- 1801836895
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 36
- Publications
- 20
Are you this provider?
Claim Your Profile